Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Surgery. 2012 Feb;151(2):232-7. doi: 10.1016/j.surg.2010.10.017. Epub 2010 Dec 22.
Surgeons have attempted to prevent early cancer-related death after resection of hepatocellular carcinoma to identify risk factors associated with early death from hepatocellular carcinoma recurrence after liver resection.
The study group comprised 350 patients who had undergone liver resection for hepatocellular carcinoma between 1997 and 2007. The preoperative risk factors for early death from intrahepatic recurrence (within 1 year after resection) were evaluated.
Fourteen (4%) patients died of intrahepatic recurrence in the first year after resection. Multivariate analyses identified the following risk factors for early cancer-related death: multiple tumors (odds ratio 10.4; 95% confidence interval, 2.42-44.3; P = .002), vascular invasion (odds ratio 10.1; 95% confidence interval 2.07-50; P = .004), serum alpha-fetoprotein level >20 ng/mL (odds ratio 9.52; 95% confidence interval 1.0--84.2; P = .043), and tumor size ≥50 mm (odds ratio 4.80; 95% confidence interval 1.06-21.9; P = .042). Each of these factors was assigned a score of 1 point, and an algorithm was developed to predict the risk of early death. Outcomes did not differ significantly between patients with 3 or 4 points (P = .48) or between those with 1 or 2 points (P = .49). Patients who underwent liver resection could be stratified into the following distinct groups according to the point score and the associated 1-year survival rate and median survival (shown respectively): 0 points, 99%, and not yet; 1 or 2 points, 96%, and 68 months; and 3 or 4 points, 50%, and 12 months) (P < .0001).
Even if hepatocellular carcinoma is resectable, patients with a score of 3 or 4 points may not be good candidates for liver resection.
外科医生试图预防肝癌切除术后与早期癌症相关的死亡,以确定与肝癌切除术后肝内复发相关的早期死亡的风险因素。
本研究组纳入了 1997 年至 2007 年间接受肝癌切除术的 350 例患者。评估了术后 1 年内肝内复发(切除后 1 年内)的早期死亡的术前危险因素。
术后 1 年内有 14 例(4%)患者死于肝内复发。多因素分析确定了与早期癌症相关死亡的以下风险因素:多个肿瘤(优势比 10.4;95%置信区间,2.42-44.3;P=.002)、血管侵犯(优势比 10.1;95%置信区间,2.07-50;P=.004)、血清甲胎蛋白水平>20ng/ml(优势比 9.52;95%置信区间,1.0-84.2;P=.043)和肿瘤直径≥50mm(优势比 4.80;95%置信区间,1.06-21.9;P=.042)。将每个因素赋值为 1 分,并制定了一种算法来预测早期死亡的风险。具有 3 分或 4 分的患者之间(P=.48)或具有 1 分或 2 分的患者之间(P=.49)的结果无显著差异。根据分数和相关的 1 年生存率和中位生存时间(分别显示),患者可分为以下不同的组别:0 分,99%,未达到;1 分或 2 分,96%,68 个月;3 分或 4 分,50%,12 个月)(P<.0001)。
即使肝癌可切除,评分 3 分或 4 分的患者可能不是肝切除术的合适人选。